Wearable
Drug Delivery Pump for Human Market
Wearable Drug Delivery Pump for Human Market
Scope: Industry Analysis, Market Size, Growth,
Trends Till 2031
Request Sample Report
Wearable Drug Delivery Pump for Human Market Size and Growth
The wearable drug delivery pump market for humans is experiencing robust growth, driven by increasing chronic disease prevalence and demand for personalized therapy. As of 2023, the market is valued at approximately $5 billion, with projections indicating a compound annual growth rate exceeding 15% over the next five years, reflecting strong innovation and adoption. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Celanese Healthcare
◍ Sonceboz
◍ Enable Injections
◍ Ypsomed
◍ Sagentia Innovation
◍ BD
◍ West Pharmaceutical
◍ Nemera
◍ NOVO Engineering
The wearable drug delivery pump market features key players like Celanese Healthcare, Enable Injections, and Ypsomed, focusing on enhancing patient compliance and automating drug administration. Their innovations drive market growth by improving safety and efficiency. Specific sales revenues include:
- BD: $18.3 billion
- West Pharmaceutical: $2.4 billion
- Ypsomed: $310 million
Request Sample Report
Market Segmentation
By Application
Hospital
Clinic
Others
Request Sample Report
By Product
Disposable Product
Recyclable Product
Market Growth
Request Sample Report
$ X Billion USD
